Szwajcaria -
włoski -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin patch sandoz 5 cerotto transdermico
sandoz pharmaceuticals ag - rivastigminum - cerotto transdermico - rivastigminum 9 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 5 cm², cum liberatione 4.6 mg/24h. - demenza di tipo alzheimer - synthetika
Szwajcaria -
włoski -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin patch sandoz 10 cerotto transdermico
sandoz pharmaceuticals ag - rivastigminum - cerotto transdermico - rivastigminum 18 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 10 cm², cum liberatione 9.5 mg/24h. - demenza di tipo alzheimer - synthetika
Szwajcaria -
włoski -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin patch sandoz 15 cerotto transdermico
sandoz pharmaceuticals ag - rivastigminum - cerotto transdermico - rivastigminum 27 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 15 cm², cum liberatione 13.3 mg/24h. - demenza di tipo alzheimer - synthetika
Szwajcaria -
włoski -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin-mepha patch 4.6mg/24h cerotti transdermici
mepha pharma ag - rivastigminum - cerotti transdermici - rivastigminum 6,9 mg, excipiens per la preparazione per il 4.6 cm2 con la liberazione di 4,6 mg/24 ore. - demenza di tipo alzheimer - synthetika
Szwajcaria -
włoski -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin-mepha patch 9.5mg/24h cerotti transdermici
mepha pharma ag - rivastigminum - cerotti transdermici - rivastigminum di 13,8 mg, excipiens per la preparazione per la 9.2 cm2 con la liberazione di 9,5 mg/24 ore. - demenza di tipo alzheimer - synthetika
Szwajcaria -
włoski -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin-mepha patch 13.3mg/24h cerotti transdermici
mepha pharma ag - rivastigminum - cerotti transdermici - rivastigminum 20.7 mg, excipiens per la preparazione per il 13.8 cm2 con la liberazione del 13,8 mg/24h. - demenza di tipo alzheimer - synthetika
Szwajcaria -
włoski -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin zentiva patch 13.3 mg/24 h cerotto transdermico
helvepharm ag - rivastigminum - cerotto transdermico - rivastigminum 19.2 mg, excipiens ad praeparationem pro 12.8 cm² cum liberatione 13.3 mg/24h. - demenza di tipo alzheimer - synthetika
Szwajcaria -
włoski -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin-mepha patch 4.6 mg/24 h cerotti transdermici
mepha pharma ag - rivastigminum - cerotti transdermici - rivastigminum 6.4 mg, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, polyisobutylenum, silica colloidalis anhydrica, paraffinum perliquidum, trägermaterial: polyethylenum/aluminium polyesterum, polyesterum, ad praeparationem pro 4.3 cm², cum liberatione 4.6 mg/24h. - demenza di tipo alzheimer - synthetika
Szwajcaria -
włoski -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin-mepha patch 9.5 mg/24 h cerotti transdermici
mepha pharma ag - rivastigminum - cerotti transdermici - rivastigminum 12.8 mg, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, polyisobutylenum, silica colloidalis anhydrica, paraffinum perliquidum, trägermaterial: polyethylenum/aluminium polyesterum, polyesterum, ad praeparationem pro 8.5 cm², cum liberatione 9.5 mg/24h. - demenza di tipo alzheimer - synthetika
Szwajcaria -
włoski -
Swissmedic (Swiss Agency for Therapeutic Products)
rivastigmin-mepha patch 13.3 mg/24 h cerotti transdermici
mepha pharma ag - rivastigminum - cerotti transdermici - rivastigminum 19.2 mg, 2-ethylhexylis acrylatis et vinylis acetatis polymerisatum, polyisobutylenum, silica colloidalis anhydrica, paraffinum perliquidum, trägermaterial: polyethylenum/aluminium polyesterum, polyesterum, ad praeparationem pro 12.8 cm², cum liberatione 13.3 mg/24h. - demenza di tipo alzheimer - synthetika